Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-11-30
1993-06-08
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530324, 530325, 930170, 930DIG800, 930DIG820, 930DIG821, A61K 3702, C07K 710
Patent
active
052179532
ABSTRACT:
The present invention relates to a peptide encoding an antagonist of VIP. The invention also relates to a method of using said peptide to antagonize VIP function. The invention further relates to a pharmaceutical composition.
REFERENCES:
patent: 3879371 (1975-04-01), Said et al.
patent: 4939224 (1990-07-01), Musso et al.
Endo et al, Endocrinol. Japan, vol. 34(6), pp. 927-935, (1987).
Tischler et al, The Journal of Neuroscience, vol. 4 (5), pp. 1398-1404, (May 1984).
Weihe et al, Cell Tissue Res., vol. 236, pp. 527-540, (1984).
Gozes et al, Endocrinology, vol. 125, No. 6, pp. 2945-2949, (Dec. 1989).
Gerdin et al, Biochimica et Biophysica Acta, vol. 757, pp. 366-370, (1983).
Couvineau et al, Biochemical and Biophysical Research Communications, vol. 121, No. 2, pp. 493-498, (1984).
Fournier et al, Peptides, vol. 8, pp. 169-177, (1984).
Robberecht et al, Eur. J. Biochem., vol. 159, pp. 45-49, (1986).
Schaaper et al, Peptides, vol. 8, pp. 167-168. (1984).
Tachibana et al, Peptide Chemistry, T. Shiba & S. Sakakibara (Ed), (1988).
Turner et al, Peptides, vol. 7, pp. 849-854, (1986).
The Merck Manual of Diagnosis and Therapy, 11th Ed. pp. 1368-1371, (1966).
Brenneman Douglas E.
Fridkin Mati M.
Gozes Illana
Moody Terry
Cashion Jr. Merrell C.
The United States of America as represented by the Secretary of
Wessendorf T. D.
LandOfFree
Vasoactive intestinal peptide antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vasoactive intestinal peptide antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasoactive intestinal peptide antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1934125